KOREA WHO
-
-
-
Chair of the Board of PharmaResearch
Jung Sang-soo
Daewoong Veteran Develops Gangneung Salmon PDRN, PN, Expands Globally
-
Last Updated on Jul 10, 2026
-
Chair of the Board of PharmaResearch
Life Summary
Jung Sang-soo is the founder and chair of the board of directors of PharmaResearch.
He is actively expanding the medical device and cosmetics businesses under the “Rejuran” and “Conjuran” brands. He is particularly focused on expanding the company’s presence in global markets.
He was born on April 25, 1958, in Gangneung, Gangwon Province.
He graduated from Gangneung High School and the College of Pharmacy at Chung-Ang University.
He worked at Daewoong Pharmaceutical as a development team leader and an expert in global pharmaceutical regulatory approval.
In 1993, he founded PharmaResearch Products, now PharmaResearch.
He has served as chair of the board since the company shifted to a professional management system in 2020.
He successfully conducted research and development on PN, or polynucleotide, and PDRN, or polydeoxyribonucleotide, using salmon from his hometown of Gangneung, helping PharmaResearch grow into a financially sound company.
He sees pharmaceuticals, including botulinum toxin, PDRN/PN-based medicines and anticancer drugs, as future growth engines.
#JungSangsoo #PharmaResearch #Rejuran #Conjuran #medicaldevices #cosmetics #polynucleotide #PDRN #botulinumtoxin #pharmaceuticals
He is actively expanding the medical device and cosmetics businesses under the “Rejuran” and “Conjuran” brands. He is particularly focused on expanding the company’s presence in global markets.
He was born on April 25, 1958, in Gangneung, Gangwon Province.
He graduated from Gangneung High School and the College of Pharmacy at Chung-Ang University.
He worked at Daewoong Pharmaceutical as a development team leader and an expert in global pharmaceutical regulatory approval.
In 1993, he founded PharmaResearch Products, now PharmaResearch.
He has served as chair of the board since the company shifted to a professional management system in 2020.
He successfully conducted research and development on PN, or polynucleotide, and PDRN, or polydeoxyribonucleotide, using salmon from his hometown of Gangneung, helping PharmaResearch grow into a financially sound company.
He sees pharmaceuticals, including botulinum toxin, PDRN/PN-based medicines and anticancer drugs, as future growth engines.
#JungSangsoo #PharmaResearch #Rejuran #Conjuran #medicaldevices #cosmetics #polynucleotide #PDRN #botulinumtoxin #pharmaceuticals